bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2019: J M A M F J
2018: D N O S A J J

 
  Other news for:
Alzheimer Disease
Brain
Genetics
 Resources from HONselect
Scientists Find 5 New Genes That Sway Alzheimer's Risk

By Robert Preidt

FRIDAY, March 1, 2019 (HealthDay News) -- The largest study to date of the genetic underpinnings of Alzheimer's has uncovered five new gene mutations that make people more vulnerable to the memory-robbing disease.

The international team of scientists analyzed the DNA of more than 94,000 people collected by the four groups that make up the International Genomic Alzheimer's Project.

"The ability to combine data from so many research groups gave us the power to detect new links to the causes of Alzheimer disease," said study co-lead author Brian Kunkle. He is an associate scientist at the University of Miami's John P. Hussman Institute for Human Genomics.

Margaret Pericak-Vance, director of the institute, added that "this is an exciting time to be studying Alzheimer disease" -- the most common cause of dementia in the elderly.

"Genes contain the body's instruction manuals, and we now have a much better understanding of how to read the instructions related to Alzheimer disease as the initial step to translation to clinical care," she explained in a University of Miami news release.

Learning more about how the five gene variants influence Alzheimer's risk could improve knowledge on how the disease begins and provide potential new targets for drugs, the study authors said.

The researchers also found that certain gene variants that bind to a protein called tau may affect development of Alzheimer's at an earlier stage than previously thought. And they discovered a formerly unknown common feature between early-onset and late-onset Alzheimer disease -- how certain proteins called amyloid precursor proteins are broken down.

The latter finding suggests that some treatments developed for early-onset Alzheimer's may also work for late-onset disease, according to the study published Feb. 28 in the journal Nature Genetics.

The investigators also found that rare genetic variants -- those that occur in less than 1 percent of a population -- likely play an important role in Alzheimer disease.

Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. In most people with Alzheimer's, symptoms first appear in their mid-60s. According to the U.S. National Institute on Aging, more than 5.5 million Americans may have Alzheimer's.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.

SOURCE: University of Miami, news release, Feb. 28, 2019

Copyright © 2019 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=743321

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Risk
Alzheimer Disease
Brain
Research Personnel
Proteins
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact